Brain regional substrates for the actions of the novel wake-promoting agent
modafinil in the rat: comparison with amphetamine
by
Engber TM, Dennis SA, Jones BE, Miller MS, Contreras PC
Department of Pharmacology,
Cephalon, Inc.,
West Chester, PA 19380, USA.
Neuroscience 1998 Dec; 87(4):905-11
ABSTRACT
Modafinil is a novel wake-promoting compound for which the mechanism and
sites of action are unknown. We examined the neural substrates in the brain for
the actions of modafinil using 2-deoxyglucose autoradiography and compared the
findings to those obtained with amphetamine. Modafinil showed a relatively
restricted pattern of changes in brain regional metabolic activity, while
amphetamine altered glucose utilization in a wide variety of brain regions. Both
modafinil and amphetamine increased glucose utilization in all subregions of the
hippocampus (subiculum, CA1-CA3 and dentate gyrus) and in the centrolateral
nucleus of the thalamus. Modafinil also increased glucose utilization in the
central nucleus of the amygdala, but amphetamine had no effect in this region.
Brain structures in which amphetamine increased metabolic rate but modafinil had
no effect included regions of the basal ganglia, other nuclei of the thalamus,
the frontal cortex, the nucleus accumbens, the ventral tegmental area and the
pontine reticular fields. These findings suggest that, while both modafinil and
amphetamine promote wakefulness, they act via distinctly different mechanisms.
Modafinil appears to act on a specific subset of brain pathways which regulate
sleep and wakefulness, whereas amphetamine affects a greater number of cerebral
structures involved in the regulation of these behavioral states. Modafinil also
lacks the pronounced effects on the extrapyramidal motor system which are
characteristic of amphetamine and other psychomotor stimulants, implying that
the effects of modafinil are not mediated by the dopamine system and that
modafinil may selectively increase wakefulness with fewer side effects.
EEG
ADHD
GABA
Orexins
Dosage
Switching
Glutamate
Modafinil: review
Modafinil: structure
Modafinil and the aviator
Modafinil: pharmacokinetics
Modafinil and the marmoset
Modafinil versus methylphenidate
Modafinil and dextroamphetamine
Modafinil, amphetamine and sleep
Modafinil v amphetamine v placebo
[an error occurred while processing this directive]